Sciele Pharma, Inc. et al v. Lupin Ltd. et al > Summary
Court Case Number 1:09-cv-00105
Filing Date Jan 16, 2009
Termination Date Feb 20, 2009
Court Maryland District Court
Status Statistical Closing
Plaintiff
5Plaintiff Attorneys
16Sciele Pharma, Inc.
Attorney Name: Geoffrey H. Genth
Kramon & Graham
Andrx Corporation
Attorney Name: Joshua A. Glikin
Bowie & Jensen LLC
ANDRX LABORATORIES (NJ) INC.
Attorney Name: Joshua A. Glikin
Bowie & Jensen LLC
andrx labs
Attorney Name: Joshua A. Glikin
Bowie & Jensen LLC
Andrx Corporation
Attorney Name: Joshua A. Glikin
Bowie & Jensen LLC
Andrx Corporation
Attorney Name: Joshua A. Glikin
Bowie & Jensen LLC
Andrx Corporation
Attorney Name: Joshua A. Glikin
Bowie & Jensen LLC
Sciele Pharma, Inc.
Attorney Name: Andrew Jay Graham
Kramon & Graham
Andrx Corporation
Attorney Name: Matthew G. Hjortsberg
Bowie & Jensen LLC
ANDRX LABORATORIES (NJ) INC.
Attorney Name: Matthew G. Hjortsberg
Bowie & Jensen LLC
andrx labs
Attorney Name: Matthew G. Hjortsberg
Bowie & Jensen LLC
Andrx Corporation
Attorney Name: Matthew G. Hjortsberg
Bowie & Jensen LLC
Andrx Corporation
Attorney Name: Matthew G. Hjortsberg
Bowie & Jensen LLC
Andrx Corporation
Attorney Name: Matthew G. Hjortsberg
Bowie & Jensen LLC
Sciele Pharma, Inc.
Attorney Name: Preston K. Ratliff II
Paul Hastings
Sciele Pharma, Inc.
Attorney Name: Bruce M. Wexler
Paul Hastings
Defendant Attorneys
2Lupin Pharmaceuticals
Attorney Name: D. Christopher Ohly
ArentFox Schiff
Lupin Pharmaceuticals
Attorney Name: D. Christopher Ohly
ArentFox Schiff
Counter Defendant
2Lupin Pharmaceuticals
Attorney Name: D. Christopher Ohly
ArentFox Schiff
Lupin Pharmaceuticals
Attorney Name: D. Christopher Ohly
ArentFox Schiff
Counter Claimant
2Lupin Pharmaceuticals
Attorney Name: D. Christopher Ohly
ArentFox Schiff
Lupin Pharmaceuticals
Attorney Name: D. Christopher Ohly
ArentFox Schiff
Cause
35:145 Civil Action to Obtain Patent
Related Patents
Doc No | Title | Issue date |
---|---|---|
06866866 | Controlled release metformin compositions | Mar 15, 2005 |
06099859 | Controlled release oral tablet having a unitary core | Aug 8, 2000 |